| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/04/2005 | WO2005070916A1 Thiophene and furan compounds |
| 08/04/2005 | WO2005070902A1 Therapeutic agents ii |
| 08/04/2005 | WO2005070900A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors |
| 08/04/2005 | WO2005070893A2 Azadecalin glucocorticoid receptor modulators |
| 08/04/2005 | WO2005070891A2 Compounds and methods of use |
| 08/04/2005 | WO2005070430A1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 08/04/2005 | WO2005070397A1 Method of preparing low-crystallinity oltipraz or amorphous oltipraz |
| 08/04/2005 | WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof |
| 08/04/2005 | WO2005051917B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 08/04/2005 | WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators |
| 08/04/2005 | WO2005018557A3 Substituted pyridinones |
| 08/04/2005 | WO2004091485A3 Aminoquinoline compounds |
| 08/04/2005 | WO2004075840A9 Selective non-steroidal glucocorticoid receptor modulators |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 08/04/2005 | US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/04/2005 | US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 08/04/2005 | US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic |
| 08/04/2005 | US20050171185 Indole derivatives |
| 08/04/2005 | US20050171180 by targeting beta and gamma secretase enzyme decreases production of amyloid precursor protein; 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide; Alzheimer's Disease, Down's Syndrome, cognitive decline |
| 08/04/2005 | US20050171164 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 08/04/2005 | US20050171156 Prodrugs of potassium channel inhibitors |
| 08/04/2005 | US20050171154 Carboxylic acid amides |
| 08/04/2005 | US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease |
| 08/04/2005 | US20050171132 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists |
| 08/04/2005 | US20050171131 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone |
| 08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 08/04/2005 | DE10361713A1 Use of oligo-thiophene or oligo-pyrrole compounds or metal-phthalocyanine complexes as electron donors in charge transfer complexes for use in non-volatile memory elements, e.g. multi-bit memory elements |
| 08/04/2005 | DE102004002044A1 Herstellverfahren Manufacturing process |
| 08/04/2005 | CA2554588A1 Method of preparing low-crystallinity oltipraz or amorphous oltipraz |
| 08/04/2005 | CA2553513A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors |
| 08/04/2005 | CA2552419A1 Azadecalin glucocorticoid receptor modulators |
| 08/03/2005 | EP1559714A1 Process for the preparation of 2-alkyl-3-aminothiophene derivatives and 3-aminothiophene derivatives |
| 08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 08/03/2005 | EP1559428A1 Receptor regulator |
| 08/03/2005 | EP1558608A1 Oxindole substituted piperazine derivatives |
| 08/03/2005 | EP1558607A1 Compositions useful as inhibitors of rock and other protein kinases |
| 08/03/2005 | EP1558606A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 08/03/2005 | EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis |
| 08/03/2005 | EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
| 08/03/2005 | EP1558572A2 Novel compounds and their use as prar-modulators |
| 08/03/2005 | EP1558571A1 Novel compounds useful in treating ppar mediated diseases |
| 08/03/2005 | EP1558341A2 Transcription factor modulating compounds and methods of use thereof |
| 08/03/2005 | EP1558260A2 Quinazolinone compounds as calcilytics |
| 08/03/2005 | EP1558247A1 Benzimidazole derivatives |
| 08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 08/03/2005 | EP1016661B1 2,6-dichloro-4-pyridinemethanol derivatives as agricultural chemicals |
| 08/03/2005 | EP0946550B1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL)METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE |
| 08/03/2005 | CN1649859A Substituted phenylacetamides and their use as glucokinase activators |
| 08/03/2005 | CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649830A Substituted aryl ketones |
| 08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
| 08/03/2005 | CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 08/03/2005 | CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924376 Compounds, compositions and methods |
| 08/02/2005 | US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | CA2446939C Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| 08/02/2005 | CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 07/28/2005 | WO2005068456A1 Production method |
| 07/28/2005 | WO2005068448A1 Sulfonamides antagonising n-type calcium channels |
| 07/28/2005 | WO2005068439A1 Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof |
| 07/28/2005 | WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005068413A1 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound |
| 07/28/2005 | WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 07/28/2005 | WO2005032490A3 Cyclic diamines and derivatives as factor xa inhibitors |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
| 07/28/2005 | US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050164992 Treating inflammatory bowel disease by administering prostaglandin derivatives such as (3-{(1R,4S,5S)-5-(3-chloro-benzo[b]thiophen-2-yl)-3-hydroxy-pent-1-enyl]-4-hydroxy-3,3-dimethyl-2-oxo-cyclopentylsulfanyl}-propylsulfanyl)-acetic acid methyl ester |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |